Atkins Whitley C, McDermott Brendon P, Colburn Abigail T, Kavouras Stavros A
Exercise Science Research Center, Department of Health and Human Performance, Fayetteville, AR, United States.
Hydration Science Laboratory, Arizona State University, Tempe, AZ, United States.
Front Sports Act Living. 2022 Apr 25;4:857719. doi: 10.3389/fspor.2022.857719. eCollection 2022.
The purpose of our study was to determine the responses to an acute water bolus in long-term oral contraception (OCP) users. Seventeen female volunteers (27 ± 5 y, 64.1 ± 13.7 kg, 39.6 ± 5.9 kg/LBM) provided consent and enrolled in our study. All were long-term OCP users and participated in two trials, one during the active pill (High Hormone, HH) dose of their prescribed OCP and one during the sham pill (Low Hormone, LH) dose. Participants reported to the laboratory euhydrated, were fed breakfast, remained seated for 60 min and were provided a bolus of room temperature water in the amount of 12 mL/kg/LBM. Urine output over 180 min was measured. Nude body mass was measured pre- and post-trial. Urine specific gravity (USG) and urine osmolality were analyzed. Between trials, there were no differences in 3-h total urine volume ( = 0.296), 3-h USG ( = 0.225), 3-h urine osmolality ( = 0.088), or 3-h urine frequency ( = 0.367). Heart rate was not different between trials ( = 0.792) nor over time ( = 0.731). Mean arterial pressure was not different between trials ( = 0.099) nor over time ( = 0.262). Perceived thirst demonstrated a significant main effect for increasing over time regardless of trial ( < 0.001) but there was no difference between trials ( = 0.731). The urgency to void was not different between trials ( = 0.149) nor over time ( = 0.615). Plasma volume change was not different between trials ( = 0.847) (HH: -3.4 ± 5.0, LH post: -3.8 ± 4.5%) and plasma osmolality did not differ between trials ( = 0.290) nor over time ( = 0.967) (HH pre: 290 ± 4, HH post: 289 ± 4, LH pre: 291 ± 4, LH post: 291 ± 4 m/L). Blood glucose significantly decreased over time ( < 0.001) but there was no difference between trials ( = 0.780) (HH pre: 95.9 ± 113.9, HH post: 86.8 ± 6.5, LH pre: 95.9 ± 13.5, LH post: 84.6 ± 9.4 mmol/L). Copeptin concentration did not differ between phases of OCP use ( = 0.645) nor from pre- to post-trial ( = 0.787) Despite fluctuations in hormone concentrations, responses to a water bolus seem to be unaffected in OCP users in euhydrated, resting conditions.
我们研究的目的是确定长期口服避孕药(OCP)使用者对急性水负荷的反应。17名女性志愿者(27±5岁,64.1±13.7千克,39.6±5.9千克瘦体重)提供了知情同意并参与了我们的研究。所有受试者均为长期OCP使用者,参与了两项试验,一项在其处方OCP的活性药丸(高激素,HH)剂量期间进行,另一项在安慰剂药丸(低激素,LH)剂量期间进行。受试者在实验室处于水合正常状态下报到,进食早餐,静坐60分钟,并给予每千克瘦体重12毫升的室温饮水。测量180分钟内的尿量。在试验前后测量裸体重。分析尿比重(USG)和尿渗透压。在两次试验之间,3小时总尿量(P = 0.296)﹑3小时USG(P = 0.225)﹑3小时尿渗透压(P = 0.088)或3小时排尿频率(P = 0.367)没有差异。试验之间心率无差异(P = 0.792),随时间也无差异(P = 0.731)。平均动脉压在试验之间无差异(P = 0.099),随时间也无差异(P = 0.262)。无论试验如何,主观口渴感随时间推移均有显著的主效应增加(P < 0.